Gillespie B. Model-based Meta-analysis for Integration of Data from Multiple Sources. Presented at: Drug Information Association Workshop, Exposure/Response Best Practice: Design, Analysis and Review; Session 1; December 5, 2005; Philadelphia, PA.
Houk B, Garrett M, Bello C, Poland B, Wagg J, Gao Y. Population Pharmacokinetics (PK) of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Oncology Patients and Healthy Volunteers [poster]. Presented at: AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; November 14-18, 2005; Philadelphia, PA. Poster Abstract (B171) available at: http://www.aacr.org.
Houk B, Bello C, Garrett M, Poland B, Wagg J, Wada R, Motzer R, Rosen L, Demetri G. Population Pharmacokinetic (PK)-pharmacodynamic (PD) Meta-analysis of Sunitinib Malate (SU11248) Efficacy and Tolerability Endpoints in Gastrointestinal Stromal Tumor (GIST), Metastatic Renal Cell Carcinoma (MRCC), and Solid Tumor Patients [poster]. Presented at: AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; November 14-18, 2005; Philadelphia, PA. Poster Abstract (B174) available at: http://www.aacr.org.
Bruno R. Impact of PK/PD Modeling and Simulation in Drug Development.
Presented at: 13th North American International Society for the Study of Xenobiotics (ISSX)/20th Japanese Society for the Study of Xenobiotics (JSSX) Joint Meeting; October 23, 2005; Maui, Hawaii. Presentation delivered at invitation of Dr. Yusuke Tanigawara as part of short course entitled "Pharmacokinetics and Pharmacodynamics Bridging."